Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP-C1 in Metastatic Breast Cancer
NCT02783794Phase 2Completed
- Sponsor
- Meabco A/S
- Start
- Dec 2012
- Primary completion
- Feb 2014
- Modality
- Polymer-based Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing BP-C1 with Placebo (2 arms). Primary endpoint: Change (%) in the sum of diameters of target lesions at Day 32. Started Dec 2012; status: completed.
02
Drugs
BP-C1
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02783794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783794.